Ameriprise
NHC icon

Ameriprise’s National Healthcare NHC Stock Holding History

Ameriprise’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Sell
20,998
-1,269
-6% -$195K ﹤0.01% 2693
2025
Q4 		$3.05M Sell
22,267
-1,133
-5% -$146K ﹤0.01% 2772
2025
Q3 		$2.84M Sell
23,400
-1,314
-5% -$142K ﹤0.01% 2797
2025
Q2 		$2.65M Sell
24,714
-1,406
-5% -$141K ﹤0.01% 2789
2025
Q1 		$2.42M Sell
26,120
-1,094
-4% -$106K ﹤0.01% 2799
2024
Q4 		$2.93M Sell
27,214
-2,672
-9% -$325K ﹤0.01% 2715
2024
Q3 		$3.76M Sell
29,886
-6,499
-18% -$817K ﹤0.01% 2568
2024
Q2 		$3.94M Sell
36,385
-1,855
-5% -$181K ﹤0.01% 2480
2024
Q1 		$3.61M Sell
38,240
-9,315
-20% -$882K ﹤0.01% 2565
2023
Q4 		$4.4M Sell
47,555
-78,922
-62% -$6.05M ﹤0.01% 2455
2023
Q3 		$8.09M Sell
126,477
-3,500
-3% -$224K ﹤0.01% 1877
2023
Q2 		$8.04M Buy
129,977
+113,625
+695% +$6.74M ﹤0.01% 1975
2023
Q1 		$950K Buy
16,352
+4,705
+40% +$270K ﹤0.01% 3177
2022
Q4 		$693K Buy
+11,647
New +$706K ﹤0.01% 3282
2020
Q4 		– Sell
-4,941
Closed -$308K – 3808
2020
Q3 		$308K Buy
+4,941
New +$309K ﹤0.01% 3418
2020
Q2 		– Sell
-2,767
Closed -$200K – 3718
2020
Q1 		$200K Buy
+2,767
New +$219K ﹤0.01% 3438
2019
Q2 		– Sell
-3,512
Closed -$268K – 3759
2019
Q1 		$268K Sell
3,512
-103
-3% -$8.17K ﹤0.01% 3479
2018
Q4 		$285K Buy
3,615
+3,573
+8,507% +$280K ﹤0.01% 3369
2018
Q3 		$3K Buy
+42
New +$3.09K ﹤0.01% 3712
2014
Q4 		– Sell
-1,435
Closed -$80K – 4157
2014
Q3 		$80K Sell
1,435
-2,660
-65% -$150K ﹤0.01% 3778
2014
Q2 		$231K Sell
4,095
-860
-17% -$46.8K ﹤0.01% 3260
2014
Q1 		$277K Buy
4,955
+2,585
+109% +$135K ﹤0.01% 3134
2013
Q4 		$128K Sell
2,370
-760
-24% -$38.9K ﹤0.01% 3308
2013
Q3 		$149K Buy
3,130
+2,160
+223% +$103K ﹤0.01% 3298
2013
Q2 		$46K Buy
+970
New +$45.3K ﹤0.01% 3757

Other funds holding NHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise's NHC Position: Q1 2026 in Review

Ameriprise reduced its National Healthcare (NHC) stake by 5.7% in Q1 2026, selling an estimated $195K and leaving 20,998 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Ameriprise first reported a position in NHC in Q2 2013 and has held it in 25 quarters since. The position peaked at $8.09M in Q3 2023. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Ameriprise held 20,998 shares of National Healthcare worth $3.35M as of Q1 2026.
  • Ameriprise sold 1,269 National Healthcare shares in Q1 2026, an estimated $195K.
  • National Healthcare made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2693 holding.
  • Ameriprise first reported a position in National Healthcare in Q2 2013 and has held it in 25 quarters since.
  • Ameriprise's National Healthcare position peaked at $8.09M in Q3 2023.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.